Charles River Laboratories International (CRL) Long-Term Investments (2010 - 2025)

Charles River Laboratories International's Long-Term Investments history runs 9 years deep, the most recent figure standing at $207.0 million for Q4 2025.

• In Q4 2025, Long-Term Investments fell 5.21% year-over-year to $207.0 million; the TTM figure through Dec 2025 stood at $207.0 million (down 5.21% YoY), while the FY2025 annual figure was $207.0 million, down 5.21% from the prior year.
• Long-Term Investments was $207.0 million for Q4 2025 at Charles River Laboratories International, up from $194.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $218.4 million in Q4 2024 to a low of $60.6 million in Q1 2022.
• Historically, Long-Term Investments has averaged $158.1 million across 5 years, with a median of $158.6 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments soared 189.5% in 2023, then tumbled 37.25% in 2024.
• A 5-year view of Long-Term Investments shows it stood at $149.6 million in 2021, then climbed by 22.02% to $182.6 million in 2022, then tumbled by 32.83% to $122.7 million in 2023, then surged by 78.02% to $218.4 million in 2024, then declined by 5.21% to $207.0 million in 2025.
• The last three Long-Term Investments figures came in at $207.0 million (Q4 2025), $194.6 million (Q3 2025), and $216.1 million (Q2 2025), per Business Quant data.